Ischemic Stroke Industry Insight
A report by Market Research Future (MRFR) on the global ischemic stroke market 2020 is brief of the forces that aided market growth in the course of the COVID 19 outbreak. The report has been drafted to delve into the prime trends prevailing in the global healthcare industry. Keeping the fact, the global market for ischemic stroke is poised to grow at an approximate CAGR of 8.3% during the years 2017–2023.
You Can Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5423
Ischemic Stroke Boomers & Decliners
The mounting prevalence of acute ischemic stroke cases is motivating the global demand for both diagnostic and surgical procedures in acute stroke treatment. Technological advancements in surgical procedures, along with an increasingly aging population, improved minimally invasive procedures demand, and expansion in health care spending is the other foremost factors motivating the growth of the global acute ischemic stroke market.
CT scan is the most widespread technique, which is used for the diagnosis of ischemic cerebral stroke, significantly owing to its competence to capture the images in the form of axial slices or as volume studies in three-dimensional form. These three-dimensional images offer the doctor better insight into the stroke condition. These factors are noted to be considered to the market’s growth.
In addition to imaging diagnosis, doctors also perform a lumbar puncture, and another laboratory testing such as basic chemistry panel, complete blood count, toxicology screening, and coagulation studies are contributing as prime factors for the market’s growth. These tests are performed to discover some additional disease conditions, which could hinder the treatment, such as meningitis, coagulopathy, and more concurrent illness such as hypoglycemia, diabetes, renal insufficiency, and hyponatremia.
On the other hand, technological advancement in surgical procedures and expanding healthcare expenditure are the most critical factors for growth in the global ischemic stroke market. In fact, the swelling incidence of diabetes, tobacco consumers, and aging populations are also crucial factors in determining the ischemic stroke market growth. On the contrary, the factor of extreme usage of medication for the treatment of ischemic stroke and the immense cost of surgical procedures are hindering the growth of the market.
Ischemic Stroke Market Segment Review
The ischemic stroke is studied over segments of diagnosis, drug class, surgery, and end-users.
Depending on the segment of diagnosis, the market has included Magnetic resonance imaging (MRI), Computed Tomography (CT), cerebral angiography, carotid ultrasound, echocardiography, electrocardiography, and others.
Depending on the segment of drug class, the market has included anticoagulant, tissue plasminogen activator, antihypertensive, antiplatelet, and more.
Depending on the segment of surgery, the market has included angioplasty, carotid endarterectomy, and endovascular mechanical thrombectomy.
Depending on the segment of end-user, the market has included medical institutes, hospitals & clinics, and research organizations.
Ischemic Stroke Market Regional Aspect
The Americas has emerged as the overall market for the global ischemic stroke owing to the constructive government initiatives, technological innovations, and mounting demand for ischemic stroke products. As per the American Heart Association, ischemic stroke is among the top three causes of death in the U.S. and Canada, where nearly 795,000 patients are suffering from strokes were treated in 2014.
Europe is the second prevalent global ischemic stroke market owing to the advancements in the surgical devices technology along with the expanding occurrence of acute ischemia stroke cases among the patients. In the European Union, above 31 million people are living with diabetes aged between 20 and 79. This signifies an average rate of diabetes prevalence of 8.6% of the adult population. Apart from this, other factors motivating the market include the mounting percentage of diabetes mellitus population, mainly in the developed countries of Europe.
The Asia Pacific might unfold as the most promising market for global ischemic stroke owing to the escalating prevalence of stroke cases in this region. China and India are considered as a considerable market for ischemic stroke within the anticipated period. Manufacturers are expanding their operations in the Asia Pacific region as these regions seize the immense potential for market growth.
Ischemic Stroke Market Significant Players
The significant players in the ischemic stroke market are Medtronic plc (U.S.), Cordis Corporation (U.S.), GE Healthcare (U.S.), Genentech, Inc. (U.S.), Bayer AG (Germany), Hitachi, Ltd (Japan), Sanofi (France), Philips Healthcare (U.S.), Penumbra, Inc. (U.S.), Biogen (U.S.), Pfizer Inc. (U.S.), and more.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Surgery Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 7. Global Ischemic Stroke Market, By Diagnosis
7.2 Computed Tomography (CT)
LIST OF TABLES
Table 1 Ischemic Stroke Industry Synopsis, 2017 – 2023
Table 2 Ischemic Stroke Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Ischemic Stroke Market By Region, 2017 – 2023, (USD Million)
Table 4 Ischemic Stroke Market By Diagnosis, 2017 – 2023, (USD Million)
Table 5 Ischemic Stroke Market By Drug Class, 2017 – 2023, (USD Million)
Table 6 Ischemic Stroke Market By Surgery, 2017 – 2023, (USD Million)
Table 7 Ischemic Stroke Market By End Users, 2017 – 2023, (USD Million)
Table 8 North America Ischemic Stroke Market By Diagnosis, 2017 – 2023, (USD Million)
Table 9 North America Ischemic Stroke Market By Drug Class, 2017 – 2023, (USD Million)
Table 10 North America Ischemic Stroke Market By Surgery, 2017 – 2023, (USD Million)
Browse Complete Report With More Details ( Toc, List of Tables & Figures) @
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312